Signaling studies in living cells would be greatly facilitated by the development of functional fluorescently tagged G-protein ␣ subunits. We have designed G i/o ␣ subunits fused to the cyan fluorescent protein and assayed their function by studying the following two signal transduction pathways: the regulation of G-proteingated inwardly rectifying K ؉ channels (Kir3.0 family) and adenylate cyclase. Palmitoylation and myristoylation consensus sites were removed from G i/o ␣ subunits (G i1 ␣, G i2 ␣, G i3 ␣, and G oA ␣) and a mutation introduced at Cys ؊4 rendering the subunit resistant to pertussis toxin. This construct was fused in-frame with cyan fluorescent protein containing a short peptide motif from GAP43 that directs palmitoylation and thus membrane targeting. Western blotting confirmed G i/o ␣ protein expression. Confocal microscopy and biochemical fractionation studies revealed membrane localization. Each mutant G i/o ␣ subunit significantly reduced basal current density when transiently expressed in a stable cell line expressing Kir3.1 and Kir3.2A, consistent with the sequestration of the G␤␥ dimer by the mutant G␣ subunit. Moreover, each subunit was able to support A1-mediated and D2S-mediated channel activation when transiently expressed in pertussis toxin-treated cells. Overexpression of tagged G i3 ␣ and G oA ␣ ␣ subunits reduced receptor-mediated and forskolin-induced cAMP mobilization.
The use of the green fluorescent protein (GFP) 1 from the jellyfish Aequoria victoria has had an enormous impact on cell biology (1) (2) (3) (4) (5) . Cloning techniques have enabled GFP to be fused with a protein of interest, and localization of such fusion proteins can then be studied in a dynamic fashion in living cells using fluorescence microscopy. In addition, protein-protein interactions can be studied using spectrally shifted variants of GFP and fluorescence resonance energy transfer (4, 6) . The mobility of proteins can be assessed using fluorescence recovery after photobleaching (2, 7) . It is clear that an enormous number of distinct intellectual areas have benefited from the use of this technology.
G-protein-coupled receptors (GPCRs) present at the cell membrane transduce signals to effectors via heterotrimeric G-proteins (8) . Given the importance of these pathways in physiology and pharmacology, it might be expected that fluorescent protein technologies would have a significant bearing. A major limitation, however, of these techniques is that the addition of GFP, which has a compact structure, can abolish or severely impair the function of the protein to which it is attached. However, it is apparent that some GPCRs can be fused in-frame with GFP such that function is preserved, and these have been used to study agonist-dependent receptor internalization (9) . Although it is possible to tag G␤ with these fluorescent proteins (10, 11) , the expression of functional G-protein ␣ subunits has proved more elusive. In the studies published to date, investigators have placed GFP internally in a region known to tolerate insertions (10, 12, 13) . Here we adopt a novel strategy. We fuse in a chimeric open reading frame CFP with the G-protein ␣ subunit, and membrane attachment is directed by a short peptide motif from another protein (GAP43) that leads to palmitoylation.
MATERIALS AND METHODS
Molecular Biology, Cell Culture, and Transfection-To engineer CFP-tagged G␣ subunits, we based our constructs on the ECFP-Mem vector obtained from CLONTECH. PCR primers were designed for the G i/o ␣ subunits. The forward primer included the C terminus of CFP (including the native BsrGI site) minus the stop codon in-frame with the G i/o ␣ subunit. It simultaneously introduced the mutations to remove the native myristoylation and palmitoylation signals (Fig. 1) . The reverse primer contained a NotI site and introduced the C-I mutation to render the subunit resistant to pertussis toxin (PTx) (Fig. 1) . PCR was performed using high fidelity Vent DNA polymerase (New England Biolabs), and the products were subcloned in-frame with ECFP-Mem using a BsrGI/NotI digest and standard subcloning techniques. The final cDNAs were sequenced using an automated sequencer (ABI377 from Applied Biosystems, Inc.).
Cell culture, transient transfection, and generation of HEK293 stable cell lines were as described previously (14, 15) . Stable HEK293 lines expressing G i3 ␣-CFP and G oA ␣-CFP ␣ subunits were selected with media containing 727 g/ml G418 and clonal isolates selected and screened with fluorescence microscopy.
In electrophysiological experiments transfected cells were identified by epifluorescence after transfection of the intrinsically fluorescent G-protein or after cotransfection with 50 ng of enhanced GFP-N1.
Confocal Microscopy-For the images obtained in Fig. 2A , living HEK293 cells were transiently transfected with the constructs as indicated and imaged using a Zeiss LSM510 laser scanning confocal microscope. Samples were excited using a 458-nm laser line, and images were obtained using an emission 500 -550-nm bandpass filter. For the images obtained in Fig. 2B , clonal isolates of stable HEK293 cells expressing G i3 ␣-CFP and G oA ␣-CFP ␣ subunits were imaged using a Bio-Rad Radiance 2000 laser scanning confocal microscope. Samples were excited using a 458-nm laser line, and images were obtained using a 500-nm long bandpass filter. Images were processed using Confocal Assistant version 4.02.
Biochemistry-A rabbit polyclonal antiserum that recognizes GFP and its spectral variants was obtained from CLONTECH. It was used according to the manufacturer's instructions, and preparation of cell lysates, SDS-PAGE, and immunoblotting were carried out as described previously (16, 17) .
Aggregated protein was isolated based on previously published methods (18) . Cells were harvested by scraping into ice-cold Tris-buffered saline (50 mM Tris, 150 NaCl, pH 7.4; TBS), pelleted, and resuspended in 1% deoxycholate in TBS with protease inhibitors (Complete EDTAfree, Roche Molecular Biochemicals). The samples were incubated on ice for 30 min and then centrifuged at 20,800 ϫ g at 4°C for 30 min. The pellet was resuspended in a volume of TBS equivalent to that of the supernatant, and equal quantities were denatured with 6ϫ gel loading buffer. Equal volumes were visualized using Western blotting as above.
To isolate a cytosolic and membrane fraction, HEK293 cells were harvested as above. The cell pellet was resuspended and subjected to hypotonic osmotic shock in 10 mM HEPES, pH 7.4, with protease inhibitors (Complete EDTA-free, Roche Molecular Biochemicals). After 15 min an equal volume of 500 mM sucrose, 10 mM HEPES, pH 7.4, was added, and the suspension was further fragmented by homogenization with a glass-on-glass Dounce homogenizer. This suspension was subjected to centrifugation at 1000 ϫ g for 15 min at 4°C to remove unfragmented cells and nuclei. The post-nuclear supernatant was subjected to ultracentrifugation at 100,000 ϫ g for 1 h at 4°C. The pellet was suspended and homogenized in a volume of 250 mM sucrose, 10 mM HEPES, pH 7.4, equal to that of the supernatant. Equivalent quantities were denatured with 6ϫ gel loading buffer and prepared for Western blotting as above. The supernatant represents the cytosolic fraction and the pellet the particulate fraction. Signal was quantitated from brief exposures of nitrocellulose to photographic film and was analyzed using Scion Image according to the protocols for gel quantification described in the program.
Assays for cAMP-HEK293 cells lines were loaded with 2-[ 3 H]adenine (Amersham Biosciences; 2 Ci/ml) overnight, washed with Opti-MEM (Invitrogen), and incubated in 10 M Ro-1724 in Opti-MEM for 30 min. Experiments were performed to measure basal cAMP accumulation and cAMP accumulation after treatment with 5 M NECA or 10 M forskolin for 15 min at 37°C. Experiments were performed in triplicate at least four times. Assays for cAMP were performed using dual column chromatography as described previously (14) . Results were calculated as the fraction of the total labeled pool converted to cAMP. Results are shown in the figure as a relative increase over basal accumulation.
Electrophysiology-Whole cell membrane currents were recorded using an Axopatch 200B amplifier (Axon Instruments). Patch pipettes were pulled from filamented borosilicate glass (Clark Electromedical) and had a resistance of 1.5-2.5 megohms when filled with pipette solution (see below). Prior to filling, tips of patch pipettes were coated with a parafilm/mineral oil suspension. Data were acquired and analyzed using a Digidata 1200B interface (Axon Instruments) and pClamp software (version 6.0; Axon Instruments). Cell capacitance was ϳ15 picofarads and series resistance (Ͻ10 megohms) was at least 75% compensated using the amplifier circuitry. Recordings of membrane current were commenced after an equilibration period of ϳ5 min.
Cells were perfused using a simple gravity-fed bath perfusion system. Drugs were applied using a "sewer pipe" system (Rapid Solution Changer RSC-160; Bio-Logic; experiments shown in Fig. 5 , B and C, and Fig. 6 ) as described previously (19) . Membrane currents were measured at the potential indicated, and all data are presented as mean Ϯ S.E. where n indicates the number of cells recorded from. Solutions were as follows (concentrations in mM): pipette solution, 107 KCl, 1.2 MgCl 2 , 1 CaCl 2 , 10 EGTA, 5 HEPES, 2 MgATP, 0.3 Na 2 GTP (KOH to pH 7.2, ϳ140 mM total K ϩ ); bath solution, 140 KCl, 2.6 CaCl 2 , 1.2 MgCl 2 , 5 HEPES, pH 7.4. All chemicals were from Sigma or Calbiochem. Drugs were made up as concentrated stock solutions and kept at Ϫ20°C.
Statistical Analysis-Data are presented as mean Ϯ S.E. Data were analyzed for statistical significance using either Student's t test or one-way analysis of variance with Dunnett's post hoc test as appropriate; * indicates p Յ 0.05 and *** indicates p Յ 0.001.
RESULTS AND DISCUSSION
G i/o ␣ subunits are acylated by both myristate at a glycine 2 and by palmitate at a cysteine 3. Myristoylation is irreversible, whereas palmitoylation is reversible and potentially regulated (20 -22) . G-proteins of the G i/o class are also characteristically inhibited by PTx which acts by ADP-ribosylating a cysteine four amino acids from the end of the C terminus (8) . Mutation of this residue to either glycine or isoleucine renders it resistant to the action of the toxin but still functional (23) (24) (25) . Thus by PTx treating cells to inactivate endogenously expressed G i/o ␣ subunits, it is possible to selectively study the interaction of a transfected and potentially chimeric or mutant G-protein. We have shown the usefulness of this approach for dissecting out the interaction of different receptors with different G i/o isoforms (15) . Finally, it is becoming clear that proteins are targeted to different subcellular compartments using short peptide motifs or because of post-translational modifications. Indeed, the acylation of G-protein ␣ subunits is thought to be responsible for their plasma membrane localization. Removal of these consensus sites results in cytosolic localization and failure of activation by surface membrane-located receptors (20, 26) . Furthermore, the inclusion of short peptide sequences directing palmitoylation and/or myristoylation motifs to a soluble heterologous protein results in membrane localization of the chimeric protein (20) .
Given these considerations we have constructed chimeric mutant molecules that contain the dual palmitoylation signal from GAP43, fused in-frame with CFP. This in turn is fused with the G i/o ␣ subunit (G i1 ␣, G i2 ␣, G i3 ␣, and G oA ␣) mutated so that the native myristoylation signal and palmitoylation signals are removed and a C-terminal C-I mutation renders it resistant to the actions of PTx (15, (23) (24) (25) 27) (Fig. 1) . It is unlikely that the G i/o -CFP ␣ subunit would be myristoylated or palmitoylated if the signal were not removed. However, it means a potential ambiguity is eliminated, and membrane attachment is directed solely by the engineered signal.
We first examined the subcellular distribution of these proteins. Laser scanning confocal microscopy was performed after transient transfection of these constructs into HEK293 cells. All CFP-G i/o ␣ constructs showed a qualitatively similar picture of localization. Representative images for two of these, G i2 ␣ and G oA ␣, are shown ( Fig. 2A) , and it is clear that there is prominent membrane staining. However in some images, in addition to a plasmalemmal localization, a fraction of the G i/o protein ␣ subunit is also present within the cell in intracellular structures. To facilitate the functional characterization of these chimeric proteins, we constructed monoclonal stable lines in HEK293 cells. Confocal microscopy confirmed similar localization with G i3 ␣ and G oA ␣ after stable expression (Fig. 2B) .
We next investigated the biochemical characteristics of these chimeric G-protein ␣ subunits. Western blotting confirmed that full-length proteins could be identified. A fraction of the cell lysate was immunoblotted with a commercially available antibody to GFP and its spectral variants. There is a band of the expected molecular weight present in transfected but not sham-transfected (control) cells (arrow in Fig. 3A) . There is also a background band recognized by the antibody in all lanes but this has a different mobility (ϳ in Fig. 3A ). There were no bands at the molecular weight of GFP indicating that there was little, if any, cleavage of the fusion protein. One potential explanation for the intracellular staining as shown in Fig. 2 is   FIG. 1. A schematic showing the fusion construct used in this study.
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that some of the protein resides in insoluble intracellular aggregates. We tested this by isolating aggregosomes according to established procedures (18) (see "Materials and Methods") from a clonal isolate of a HEK293 stable line expressing G oA ␣-CFP. It is apparent that some of the protein is insoluble, but the majority is present in a detergent-extractable form (Fig. 3B) . Similar results were obtained with G i3 ␣-CFP (not shown). We further investigated the membrane localization of these proteins and by performing cell fractionation studies from monoclonal isolates of HEK293 cells expressing G i3 ␣-CFP and G oA ␣-CFP. It is apparent both qualitatively and quantitatively that the majority of protein resides in a particulate fraction (Fig.  3C) . The background band (ϳ in Fig. 3, A and B) disappears after removal of the cell nuclei.
G-protein-gated inwardly rectifying potassium channels were first identified in atrial myocytes where they were activated by acetylcholine at muscarinic M 2 receptors (28, 29) . Stimulation of this current was responsible for slowing of the heart rate in response to vagal nerve stimulation. It was subsequently shown that this activation was sensitive to PTx implicating the family of G i/o proteins (30) . The channel is a heteromultimer of members of the Kir3.0 subfamily (31) (32) (33) (34) (35) . Activation of these channels, both native and cloned, has been shown to be membrane-delimited, involving a direct interaction with the G-protein ␤␥ dimer (35) . A variety of different G␤␥ subunit combinations have been shown to be similarly effective at potentiating these currents (36) with the exception of dimers composed of G␤ 5 (37) . Our own studies (14, 15, 19) have been concerned with how selective activation of Kir3.1/3.2A is achieved. By using a number of Kir3.1 ϩ 3.2A-expressing stable cell lines we have developed, some of which additionally express a GPCR, we can examine the functionality of the engineered G-protein ␣ subunit in two ways.
First, basal channel activity is determined by the availability of free G␤␥ in the membrane. By overexpressing proteins or domains of proteins known to bind G␤␥, basal channel activity can be reduced. A HEK293 stable line cell line expressing Kir3.1 and 3.2A has significant basal inwardly rectifying K ϩ currents in the absence of receptor activation (14) . We have observed previously (14, 15 ) that overexpression of G-protein ␣ subunits can suppress basal currents. Similarly, in the current study, we overexpressed the CFP-tagged G-protein ␣ subunits in this same cell line. Fig. 4A shows representative whole cell recordings, and Fig. 4B summarizes the data. Channel activity was significantly reduced indicating that these G-protein ␣ subunits can interact with G␤␥.
Second, by treating a HEK293 cell line expressing the A1 adenosine receptor and the channel complex Kir3.1/3.2A with PTx (100 ng/ml for 16 h), we abolished the coupling of the A1 receptor with endogenous G i/o ␣ subunits and subsequent channel activation (15) . In PTx-treated cells, overexpression of the CFP-tagged G i/o ␣ subunits can rescue coupling between the receptor and channel. Control is a sham transfection with a mammalian expression vector (pcDNA3.1/Zeo). Molecular weight markers are shown beside the gel (kDa), and the protein of interest is indicated by an arrow. B, soluble (S) and insoluble (IS) protein fractions were isolated from ϳ3 million cells of a clonal isolate of a HEK293 stable line expressing G oA ␣-CFP (see "Materials and Methods"). One-sixth of these samples was run on a 10% SDS-PAGE gel and subjected to Western blotting using rabbit polyclonal antisera to CFP for immunodetection of the protein. Molecular weight markers are shown beside the gel (kDa), and the protein of interest is indicated by the arrow. C, particulate (P) and cytosolic (C) fractions were isolated from ϳ3 million cells of clonal isolates of HEK293 stable lines expressing G i3 ␣-CFP and G oA ␣-CFP (see "Materials and Methods"). One-fifth of these samples were run on a 10% SDS-PAGE gel and subjected to Western blotting using a rabbit polyclonal antisera to CFP for immunodetection of the protein. 
expresses a fixed level of A1 receptor and channel complex, Kir3.1 and Kir3.2A (designated HKir3.1/3.2/A1). Fig. 5B shows current records at a fixed holding potential of Ϫ60 mV using a perfusion system that allows the rapid application of agonist. The control is shown in the upper left panel where the application of a saturating dose of NECA (1 M) results in significant current activation in HKir3.1/3.2/A1 cells. PTx completely abolished current activation (Basal ϭ Ϫ65.5 Ϯ 9.9 pA/pF; ϩ1 M NECA ϭ Ϫ57.2 Ϯ 9.3 pA/pF; Wash ϭ Ϫ56.4 Ϯ 9.0 pA/pF, n ϭ 12). In contrast, transfection of HKir3.1/3.2/A1 cells with a PTx-insensitive G␣ subunit and subsequent PTx treatment leads to rescue of coupling between receptor and channel (G i2 ␣CG, upper right panel) (15) . Analogous experiments were performed in which CFP-tagged G-protein ␣ subunits were expressed in the Kir3.1/3.2/A1 cell line. The CFP-G i2 ␣ and CFP-G oA ␣ shown in the lower panels of Fig. 5 , B and C, summarize the data from a number of experiments. It shows that the CFP-tagged G i/o variants are able to support equivalent current increases to that seen through untagged G i/o PTxresistant G-proteins (G i2 ␣ is shown as an example in Fig. 5C ) and through native G-proteins without PTx treatment. The transient increase observed in currents on removal of agonist was found consistently in a proportion of the cells studied, and we are investigating this in more detail.
Can the chimeric fluorescent G-protein ␣ subunits rescue coupling to a receptor other than the A1 receptor? We performed an analogous series of experiments to those in Fig. 5 , B and C, with a stable cell line expressing the D2S receptor and Kir3.1/3.2A (HKir3.1/3.2/D2S ). The G oA ␣-CFP construct was expressed transiently in PTx-treated cells and was able to -treated cells (1 g of cDNA for a  35-mm well transfection) . A, transient transfection of the A1 receptor and G i2 ␣-CFP construct was performed into a HEK293 cell line expressing Kir3.1/3.2A. Cells were treated with PTx (100 ng/ml) for 16 h and studied using the whole cell patch clamp technique. The application of NECA (1 M), a nonselective adenosine agonist, elicited inwardly rectifying K ϩ currents. B, membrane currents were measured at Ϫ60 mV in a stable line coexpressing the A1 receptor and Kir3.1/ 3.2A. 1 M NECA was applied using a rapid application system. A bar above the trace indicates the period of drug application, and the dotted line indicates zero current level. By using such a system, there was a short lag and then a fast rise to peak current activation. Currents subsequently desensitized during NECA application. Representative traces are shown under the conditions indicated. C, currents were measured as indicated in B, and current density was calculated. The bar graph summarizes the mean data. NS, not significant; *, p Ͻ 0.05; ***, p Ͻ 0.001.
rescue coupling between the receptor and channel complex (Fig. 6, A and B) . However, as shown previously (15) , the efficacy of coupling to the D2S receptor through mutant Gproteins was reduced compared with that occurring through endogenous G-proteins. We are currently undertaking more detailed studies of the kinetic responses of the channel to receptor stimulation using these and other tools.
Our data show that the CFP-tagged G-proteins are able to interact productively with receptors, to exchange GTP for GDP, and liberate free G␤␥ that is able to activate Kir3.1/3.2A. Finally, we investigated the functionality of these G-proteins with another signaling pathway, specifically the inhibition of adenylate cyclase. We examined the effects of overexpression of the fluorescent chimeric G-protein ␣ subunits on cAMP accumulation after receptor stimulation and after treatment with forskolin; an activator of all isoforms of adenylate cyclase. Our studies had previously revealed (14) a small but statistically significant increase in cAMP accumulation in cells treated with 1 M NECA. Other investigators (38) have shown that HEK293 cells possess an endogenous G s -coupled A2B receptor. In agreement with this, the addition of 5 M NECA led to a substantial and significant increase in cAMP in HEK293 cells and also in clonal isolates of stable cell lines expressing Kir3.1/3.2A and SUR2B/Kir6.1 (Fig. 7A) . In contrast, in clonal isolates of HEK293 stable lines overexpressing G i3 ␣-CFP (two separate isolates) and G oA ␣-CFP, the increase was essentially abolished (Fig. 7A) . The relative effects of forskolin were also examined. Similarly, 10 M forskolin led to substantial increases in cAMP in these cell lines (Fig. 7B) . However, the increase was reduced in clonal isolates of stable HEK293 lines overexpressing G i3 ␣-CFP (two separate isolates) and G oA ␣-CFP (Fig. 7B) . The difference in the magnitude of reduction, between receptor-mediated pathways and that occurring with forskolin, is explained potentially by the greater number of adenylate cyclase isoforms stimulated by forskolin. Indeed some isoforms are not sensitive to G i3 ␣ or G oA ␣ (39, 40) . Thus overexpression of these chimeric fluorescent G-proteins results in significant attenuation of cAMP signaling. Plausibly, this occurs because overexpression results in a significant (but proportionately small) fraction that is GTP bound and is active in the absence of receptor stimulation.
Our data clearly demonstrate that it is feasible to engineer a functional and fluorescent G i/o ␣ subunit. In particular, it is possible to remove the native acylation signal but generate membrane attachment and functionality by substituting the signal from another protein (GAP43) in a distinct and separate position in a chimeric molecule. It is apparent that it is possible to construct functional receptor-G-protein fusions. In this case the acylation signal is removed in an analogous fashion, and the complex is targeted to the plasma membrane by fusion in a chimeric reading frame with a receptor, a seven-pass transmembrane protein (41) . Attempts to introduce GFP into this construct led to a complex that expressed and was able to bind GTP in an agonist-dependent fashion but did not functionally couple with adenylate cyclase (42) . Our strategy is novel because it uses a short peptide motif directing lipid modification that targets the protein to the plasma membrane. Other investigators have relied on inserting the fluorescent protein in internal sites in the G-protein ␣ subunit known to tolerate the introduction of short epitopes.
GAP43 is involved in neuronal growth cone development and is membrane-targeted by a dual palmitoylation signal at Cys 3 and Cys 4 . The native signal on G i/o subunits is myristoylation and palmitoylation on Gly 2 and Cys 3 , respectively. We have also engineered, in comparable manner to that shown in Fig.  1A , a fusion that includes an analogous signal from the nonreceptor tyrosine kinase, Lyn, and this too is functional (not shown). We are actively investigating differences between 35-mm well transfection) . A, membrane currents were measured at Ϫ60 mV in a stable line coexpressing the D2S receptor and Kir3.1/3.2A. 10 M quinpirole was applied using a rapid application system. A bar above the trace indicates the period of drug application, and the dotted line indicates zero current level. By using such a system, there was a short lag and then a fast rise to peak current activation. Currents subsequently desensitized during quinpirole application. Representative traces are shown under the conditions indicated. B, currents were measured as indicated in Fig. 5B , and current density calculated. The bar graph summarizes the mean data. ***, p Ͻ 0.001. these two constructs. There has also been interest in the localization of G i/o ␣ subunits to cholesterol-rich and cold detergentinsoluble domains in the plasma membrane such as rafts and the related caveolae. There is evidence suggesting that both kinds of modification can target their cognate protein (GAP43, G i/o subunit, Lyn) to such membrane specializations (20, (43) (44) (45) (46) . Theoretically, it should be possible to design tethering signals that do not target the G-protein to rafts and thus examine the consequences for signaling (47) . Indeed, recently differential trafficking to membrane domains has been observed for a variety lipid modifications attached to fluorescent proteins (48) .
Our fluorescent G i/o ␣ subunits are novel tools that can be used to dynamically study the G i/o ␣ subunit localization, while simultaneously and selectively investigating functional consequences by treating with PTx. Furthermore, they can potentially be used for investigating protein-protein interactions using fluorescence resonance energy transfer-based technologies and G-protein mobility using fluorescence recovery after photobleaching. Finally, they provide an easy means of assessing expression level and potentially titrating this at the membrane in individual living cells. 
